Key statistics
On Friday, OptimizeRx Corp (OPRX:NAQ) closed at 10.89, 172.84% above the 52 week low of 3.99 set on Mar 11, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 10.76 |
|---|---|
| High | 10.95 |
| Low | 10.15 |
| Bid | 10.70 |
| Offer | 12.25 |
| Previous close | 10.54 |
| Average volume | 377.16k |
|---|---|
| Shares outstanding | 18.64m |
| Free float | 15.74m |
| P/E (TTM) | 7,422.54 |
| Market cap | 196.47m USD |
| EPS (TTM) | -0.0027 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
- OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
- OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
- OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
- OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
- OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
- OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
- OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
- OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
- OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
More ▼
